Factors associated with acute and late dysphagia in the DAHANCA 6 & 7 randomized trial with accelerated radiotherapy for head and neck cancer

References

• Mittal BB, Pauloski BR, Haraf DJ, Pelzer HJ, Argiris A, Vokes EE, et al. Swallowing dysfunction – preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: A critical review. Int J Radiat Oncol Biol Phys 2003; 57:1219–30.
   PubMed Web of Science ®Google Scholar
• Logemann JA, Rademaker AW, Pauloski BR, Lazarus CL, Mittal BB, Brockstein B, et al. Site of disease and treatment protocol as correlates of swallowing function in patients with head and neck cancer treated with chemoradiation. Head Neck 2006;28:64–73.
   PubMed Web of Science ®Google Scholar
• Overgaard J, Hansen HS, Specht L, Overgaard M, Grau C, Andersen E, et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 2003;362:933–40.
   PubMed Web of Science ®Google Scholar
• Langendijk JA, Doornaert P, Rietveld DH, Verdonck- de Leeuw IM, Leemans CR, Slotman BJ. A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer. Radiother Oncol 2009;90:189–95.
   PubMed Web of Science ®Google Scholar
• Golen M, Skladowski K, Wygoda A, Przeorek W, Pilecki B, Maciejewski B, et al. A comparison of two scoring systems for late radiation toxicity in patients after radiotherapy for head and neck cancer. Reports Pract Oncol Radiother 2005;10:179–92.
   Google Scholar
• Mortensen HR, Jensen K, Grau C. Aspiration pneumonia in patients treated with radiotherapy for head and neck cancer. Acta Oncol 2013;52:270–6.
   PubMed Web of Science ®Google Scholar
• Jensen K, Bonde JA, Grau C. The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires. Radiother Oncol 2006;78:298–305.
   PubMed Web of Science ®Google Scholar
• Koiwai K, Shikama N, Sasaki S, Shinoda A, Kadoya M. Risk factors for severe dysphagia after concurrent chemoradiotherapy for head and neck cancers. Jpn J Clin Oncol 2009;39:413–7.
   PubMed Web of Science ®Google Scholar
• Mangar S, Slevin N, Mais K, Sykes A. Evaluating predictive factors for determining enteral nutrition in patients receiving radical radiotherapy for head and neck cancer: A retrospective review. Radiother Oncol 2006;78:152–8.
   PubMed Web of Science ®Google Scholar
• Poulsen MG, Riddle B, Keller J, Porceddu SV, Tripcony L. Predictors of acute grade 4 swallowing toxicity in patients with stages III and IV squamous carcinoma of the head and neck treated with radiotherapy alone. Radiother Oncol 2008;87:253–9.
   PubMed Web of Science ®Google Scholar
• Salama JK, Stenson KM, List MA, Mell LK, MacCracken E, Cohen EE, et al. Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2008;134:1060–5.
   PubMedGoogle Scholar
• Nourissat A, Bairati I, Samson E, Fortin A, Gelinas M, Nabid A, et al. Predictors of weight loss during radiotherapy in patients with stage I or II head and neck cancer. Cancer 2010;116:2275–83.
   PubMed Web of Science ®Google Scholar
• Ghadjar P, Simcock M, Zimmermann F, Betz M, Bodis S, Bernier J, et al. Predictors of severe late radiotherapy-related toxicity after hyperfractionated radiotherapy with or without concomitant cisplatin in locally advanced head and neck cancer. Secondary retrospective analysis of a randomized phase III trial (SAKK 10/94). Radiother Oncol 2012;104: 213–8.
   PubMed Web of Science ®Google Scholar
• Machtay M, Moughan J, Trotti A, Garden AS, Weber RS, Cooper JS, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: An RTOG analysis. J Clin Oncol 2008;26:3582–9.
   PubMed Web of Science ®Google Scholar
• Caudell JJ, Schaner PE, Meredith RF, Locher JL, Nabell LM, Carroll WR, et al. Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2009;73:410–5.
   PubMed Web of Science ®Google Scholar
• Chen AM, Li BQ, Jennelle RL, Lau DH, Yang CC, Courquin J, et al. Late esophageal toxicity after radiation therapy for head and neck cancer. Head Neck 2010;32: 178–83.
   PubMed Web of Science ®Google Scholar
• Rutten H, Pop LA, Janssens GO, Takes RP, Knuijt S, Rooijakkers AF, et al. Long-term outcome and morbidity after treatment with accelerated radiotherapy and weekly cisplatin for locally advanced head-and-neck cancer: Results of a multidisciplinary late morbidity clinic. Int J Radiat Oncol Biol Phys 2011;81:923–9.
   PubMed Web of Science ®Google Scholar
• Koiwai K, Shikama N, Sasaki S, Shinoda A, Kadoya M. Validation of the Total Dysphagia Risk Score (TDRS) as a predictive measure for acute swallowing dysfunction induced by chemoradiotherapy for head and neck cancers. Radiother Oncol 2010;97:132–5.
   PubMed Web of Science ®Google Scholar
• Ottosson S, Zackrisson B, Kjellen E, Nilsson P, Laurell G. Weight loss in patients with head and neck cancer during and after conventional and accelerated radiotherapy. Acta Oncol 2013;52:711–8.
   PubMed Web of Science ®Google Scholar
• Eisbruch A, Schwartz M, Rasch C, Vineberg K, Damen E, Van As CJ, et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: Which anatomic structures are affected and can they be spared by IMRT?Int J Radiat Oncol Biol Phys 2004;60:1425–39.
   PubMed Web of Science ®Google Scholar
• Bhide SA, Gulliford S, Kazi R, El-Hariry I, Newbold K, Harrington KJ, et al. Correlation between dose to the pharyngeal constrictors and patient quality of life and late dysphagia following chemo-IMRT for head and neck cancer. Radiother Oncol 2009;93:539–44.
   PubMed Web of Science ®Google Scholar
• Caudell JJ, Schaner PE, Desmond RA, Meredith RF, Spencer SA, Bonner JA. Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 2010;76:403–9.
   PubMed Web of Science ®Google Scholar
• Jensen K, Lambertsen K, Grau C. Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: Frequency, intensity and correlation with dose and volume parameters. Radiother Oncol 2007;85:74–82.
   PubMed Web of Science ®Google Scholar
• Sanguineti G, Rao N, Gunn B, Ricchetti F, Fiorino C. Predictors of PEG dependence after IMRT+/-chemotherapy for oropharyngeal cancer. Radiother Oncol 2013:107:300–4.
   PubMed Web of Science ®Google Scholar
• Eisbruch A, Levendag PC, Feng FY, Teguh D, Lyden T, Schmitz PI, et al. Can IMRT or brachytherapy reduce dysphagia associated with chemoradiotherapy of head and neck cancer? The Michigan and Rotterdam experiences. Int J Radiat Oncol Biol Phys 2007;69:S40–2.
   Web of Science ®Google Scholar
• van der Laan HP, Christianen ME, Bijl HP, Schilstra C, Langendijk JA. The potential benefit of swallowing sparing intensity modulated radiotherapy to reduce swallowing dysfunction: An in silico planning comparative study. Radiother Oncol 2012;103:76–81.
   PubMed Web of Science ®Google Scholar
• van der Laan HP, van de Water TA, van Herpt HE, Christianen ME, Bijl HP, Korevaar EW, et al. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study. Acta Oncol 2013;52:561–9.
   PubMed Web of Science ®Google Scholar
• Langendijk JA, Lambin P, De RD, Widder J, Bos M, Verheij M. Selection of patients for radiotherapy with protons aiming at reduction of side effects: The model-based approach. Radiother Oncol Epub 2013:107:267–73.
   PubMed Web of Science ®Google Scholar
• van der Laan HP, Gawryszuk A, Christianen ME, Steenbakkers RJ, Korevaar EW, Chouvalova O, et al. Swallowing-sparing intensity-modulated radiotherapy for head and neck cancer patients: Treatment planning optimization and clinical introduction. Radiother Oncol Epub 2013:107:282–7.
   PubMed Web of Science ®Google Scholar
• Mortensen HR, Jensen K, Aksglæde K, Lambertsen K, Eriksen E, Grau C. Prophylactic systematic swallowing exercises in radical radiotherapy in head and neck cancer patients – a randomized trial. Submittet(in press).
   Google Scholar